{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T09:01:55Z","timestamp":1781082115250,"version":"3.54.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007397","name":"Charles University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.pbb.2026.174216","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T05:59:45Z","timestamp":1779688785000},"page":"174216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Pharmacological modulation of anxiety-like behavior by flumazenil, midazolam, and ketamine in rats: Evidence from aversive ultrasonic vocalizations and elevated plus maze"],"prefix":"10.1016","volume":"265","author":[{"given":"Marcela","family":"Unterspann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrysostomos","family":"Charalambous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Votava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ladislav","family":"Hess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Sliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Lapka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2026.174216_bb0005","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1503\/jpn.160175","article-title":"Antidepressant effects of ketamine and the roles of AMPA glutamate receptors and other mechanisms beyond NMDA receptor antagonism","volume":"42","author":"Aleksandrova","year":"2017","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.pbb.2026.174216_bb0010","doi-asserted-by":"crossref","first-page":"933","DOI":"10.2174\/1567205020666230308123718","article-title":"Effects of the recurrent and different doses of ketamine exposure on anxiety-like behaviors and locomotor activity in juvenile rats","volume":"19","author":"Arpac\u0131","year":"2022","journal-title":"CAR"},{"key":"10.1016\/j.pbb.2026.174216_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2025.110650","article-title":"Antidepressant ketamine via oral gavage impairs fear memory, suppresses 22 kHz ultrasonic vocalizations, lowers GluN2A\/B expression, and reduces medial habenula activity in rats","volume":"279","author":"Asrar","year":"2025","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2026.174216_bb0020","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2026.174216_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105396","article-title":"Playback of rat 22-kHz ultrasonic vocalizations as a translational assay of negative affective states: an analysis of evoked behavior and brain activity","volume":"153","author":"Bonauto","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pbb.2026.174216_bb0030","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0022-510X(97)05389-6","article-title":"Electrophysiological evidence for agonist properties of flumazenil, a benzodiazepine receptor antagonist, in rat hippocampus slices","volume":"149","author":"Buldakova","year":"1997","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.pbb.2026.174216_bb0035","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1553-2712.2000.tb01064.x","article-title":"A combination of midazolam and ketamine for procedural sedation and analgesia in adult emergency department patients","volume":"7","author":"Chudnofsky","year":"2000","journal-title":"Acad. Emerg. Med."},{"key":"10.1016\/j.pbb.2026.174216_bb0040","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0024-3205(88)90149-X","article-title":"Ultrasonic vocalization in response to unavoidable aversive stimuli in rats: effects of benzodiazepines","volume":"43","author":"Cuomo","year":"1988","journal-title":"Life Sci."},{"key":"10.1016\/j.pbb.2026.174216_bb0045","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0014-2999(93)90530-U","article-title":"Shock-induced ultrasonic vocalization in young adult rats: a model for testing putative anti-anxiety drugs","volume":"249","author":"De Vry","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2026.174216_bb0050","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/0028-3908(82)90118-6","article-title":"The anxiogenic action of benzodiazepine antagonists","volume":"21","author":"File","year":"1982","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2026.174216_bb0055","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12871-017-0404-5","article-title":"Ketamine attenuates the glutamatergic neurotransmission in the ventral posteromedial nucleus slices of rats","volume":"17","author":"Fu","year":"2017","journal-title":"BMC Anesthesiol."},{"key":"10.1016\/j.pbb.2026.174216_bb0060","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1177\/0269881117705089","article-title":"Ketamine\u2019s dose-related effects on anxiety symptoms in patients with treatment refractory anxiety disorders","volume":"31","author":"Glue","year":"2017","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pbb.2026.174216_bb0065","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1159\/000547982","article-title":"Effect of acute administration of different ketamine doses on anxiety and metabolic activity of the amygdala in rats","volume":"84","author":"Guevara","year":"2025","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.pbb.2026.174216_bb0070","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1192\/bjp.133.3.231","article-title":"Central actions of benzodiazepines: general introduction","volume":"133","author":"Haefely","year":"1978","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.pbb.2026.174216_bb0075","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/hup.960","article-title":"S-ketamine and GABA-A-receptor interaction in humans: an exploratory study with I-123-iomazenil SPECT","volume":"23","author":"Heinzel","year":"2008","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.pbb.2026.174216_bb0080","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/00003643-201306001-00470","article-title":"Sedative and anxiolytic properties of flumazenil in rats and rabbits: 9AP4-8","volume":"30","author":"Hess","year":"2013","journal-title":"Eur. J. Anaesthesiol."},{"key":"10.1016\/j.pbb.2026.174216_bb0085","unstructured":"M. Irifune, T. Sato, Y. Kamata, T. Nishikawa, T. Dohi, M. Kawahara, Evidence for GABAA Receptor Agonistic Properties of Ketamine: Convulsive and Anesthetic Behavioral Models in Mice, (n.d.)."},{"key":"10.1016\/j.pbb.2026.174216_bb0090","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF02245463","article-title":"Flumazenil has an anxiolytic effect in simulated stress","volume":"114","author":"Kapczinski","year":"1994","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2026.174216_bb0095","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1146\/annurev.publhealth.29.020907.090847","article-title":"The descriptive epidemiology of commonly occurring mental disorders in the United States","volume":"29","author":"Kessler","year":"2008","journal-title":"Annu. Rev. Public Health"},{"key":"10.1016\/j.pbb.2026.174216_bb0100","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41386-023-01629-w","article-title":"Ketamine and rapid antidepressant action: new treatments and novel synaptic signaling mechanisms","volume":"49","author":"Krystal","year":"2024","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.pbb.2026.174216_bb0105","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.neuropharm.2018.12.030","article-title":"Flumazenil but not bicuculline counteract the impairing effects of anesthetic ketamine on recognition memory in rats. Evidence for a functional interaction between the GABAA-benzodiazepine receptor and ketamine?","volume":"148","author":"Lafioniatis","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2026.174216_bb0110","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1126\/science.290.5489.131","article-title":"Molecular and neuronal substrate for the selective attenuation of anxiety","volume":"290","author":"L\u00f6w","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.pbb.2026.174216_bb0115","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/bs.apha.2020.03.002","article-title":"Antidepressant mechanisms of ketamine: focus on GABAergic inhibition","volume":"89","author":"Luscher","year":"2020","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.pbb.2026.174216_bb0120","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/0023677216652380","article-title":"Ketamine alone or combined with midazolam or dexmedetomidine does not affect anxiety-like behaviours and memory in adult Wistar rats","volume":"51","author":"Magalh\u00e3es","year":"2017","journal-title":"Lab. Anim"},{"key":"10.1016\/j.pbb.2026.174216_bb0125","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/75761","article-title":"Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor \u03b11 subtype","volume":"3","author":"McKernan","year":"2000","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.pbb.2026.174216_bb0130","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1192\/bjp.2024.250","article-title":"Effect of ketamine on anxiety: findings from the ketamine for adult depression study","volume":"227","author":"Mills","year":"2025","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.pbb.2026.174216_bb0135","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/cns.12099","article-title":"Ketamine pharmacology: an update (pharmacodynamics and molecular aspects, recent findings)","volume":"19","author":"Mion","year":"2013","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.pbb.2026.174216_bb0140","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s002130000507","article-title":"Enhanced ultrasonic vocalization and Fos protein expression following ethanol withdrawal: effects of flumazenil","volume":"152","author":"Moy","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2026.174216_bb0145","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/295436a0","article-title":"Unusual interactions of benzodiazepine receptor antagonists","volume":"295","author":"Nutt","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2026.174216_bb0150","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1515\/JBCPP.2000.11.2.109","article-title":"The effects of midazolam and morphine on analgesic and sedative activity of ketamine in rats","volume":"11","author":"Okulicz-Kozaryn","year":"2000","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"key":"10.1016\/j.pbb.2026.174216_bb0155","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/j.pain.2011.04.017","article-title":"Stress-induced hyperalgesia is associated with a reduced and delayed GABA inhibitory control that enhances post-synaptic NMDA receptor activation in the spinal cord","volume":"152","author":"Quintero","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.pbb.2026.174216_bb0160","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejphar.2010.03.015","article-title":"The point mutation \u03b32F77I changes the potency and efficacy of benzodiazepine site ligands in different GABAA receptor subtypes","volume":"636","author":"Ramerstorfer","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2026.174216_bb0165","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1365-2044.1990.tb14623.x","article-title":"Flumazenil in ketamine and midazolam anaesthesia","volume":"45","author":"Restall","year":"1990","journal-title":"Anaesthesia"},{"key":"10.1016\/j.pbb.2026.174216_bb0170","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/jamapsychiatry.2017.0056","article-title":"Cross-sectional comparison of the epidemiology of DSM-5 generalized anxiety disorder across the globe","volume":"74","author":"Ruscio","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.pbb.2026.174216_bb0175","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1213\/01.ANE.0000156951.83242.8D","article-title":"Subanesthetic ketamine does not affect 11C-flumazenil binding in humans","volume":"101","author":"Salmi","year":"2005","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.pbb.2026.174216_bb0180","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fnbeh.2011.00043","article-title":"A novel elevated plus-maze procedure to avoid the one-trial tolerance problem","volume":"5","author":"Schneider","year":"2011","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.pbb.2026.174216_bb0185","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1124\/pharmrev.121.000293","article-title":"\u03b16-Containing GABAA receptors: functional roles and therapeutic potentials","volume":"74","author":"Sieghart","year":"2022","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.pbb.2026.174216_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.109878","article-title":"Ketamine effects on anxiety and fear-related behaviors: current literature evidence and new findings","volume":"100","author":"Silote","year":"2020","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2026.174216_bb0195","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/(SICI)1520-6394(1997)5:1<29::AID-DA5>3.0.CO;2-0","article-title":"Acute effects of ketamine in the holeboard, the elevated-plus maze, and the social interaction test in Wistar rats","volume":"5","author":"Silvestre","year":"1997","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.pbb.2026.174216_bb0200","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2174\/1570159X13999150318113800","article-title":"Rat ultrasonic vocalizations and behavioral neuropharmacology: from the screening of drugs to the study of disease","volume":"13","author":"Simola","year":"2015","journal-title":"CN"},{"key":"10.1016\/j.pbb.2026.174216_bb0205","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/npp.2017.194","article-title":"Ketamine for social anxiety disorder: a randomized, placebo-controlled crossover trial","volume":"43","author":"Taylor","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2026.174216_bb0210","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0022-3565(24)35193-6","article-title":"Antagonist-induced reversal of functional and structural measures of hippocampal benzodiazepine tolerance","volume":"291","author":"Tietz","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2026.174216_bb0215","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1124\/pr.109.002063","article-title":"Regulation of GABAA receptor subunit expression by pharmacological agents","volume":"62","author":"Uusi-Oukari","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.pbb.2026.174216_bb0220","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jpsychires.2007.01.007","article-title":"Individual differences predict susceptibility to conditioned fear arising from psychosocial trauma","volume":"42","author":"Walker","year":"2008","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pbb.2026.174216_bb0225","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3109\/10253890802673134","article-title":"Strain differences in coping behaviour, novelty seeking behaviour, and susceptibility to socially conditioned fear: a comparison between Wistar and Sprague Dawley rats","volume":"12","author":"Walker","year":"2009","journal-title":"Stress"},{"key":"10.1016\/j.pbb.2026.174216_bb0230","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.euroneuro.2005.04.012","article-title":"Size and burden of mental disorders in Europe\u2014a critical review and appraisal of 27 studies","volume":"15","author":"Wittchen","year":"2005","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pbb.2026.174216_bb0235","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00441-013-1607-9","article-title":"Affective communication in rodents: ultrasonic vocalizations as a tool for research on emotion and motivation","volume":"354","author":"W\u00f6hr","year":"2013","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.pbb.2026.174216_bb0240","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2022.848232","article-title":"S-ketamine pretreatment alleviates anxiety-like behaviors and mechanical allodynia and blocks the pro-inflammatory response in striatum and periaqueductal gray from a post-traumatic stress disorder model","volume":"16","author":"Yang","year":"2022","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.pbb.2026.174216_bb0245","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pbb.2026.174216_bb0250","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ibror.2019.01.006","article-title":"Effects of subanesthetic intravenous ketamine infusion on neuroplasticity-related proteins in the prefrontal cortex, amygdala, and hippocampus of Sprague-Dawley rats","volume":"6","author":"Zhang","year":"2019","journal-title":"IBRO Reports"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305726000717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305726000717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T08:34:06Z","timestamp":1781080446000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305726000717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":50,"alternative-id":["S0091305726000717"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2026.174216","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological modulation of anxiety-like behavior by flumazenil, midazolam, and ketamine in rats: Evidence from aversive ultrasonic vocalizations and elevated plus maze","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2026.174216","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"174216"}}